Platysma synkinesis in facial palsy and botulinum toxin type A

Laryngoscope

Volumn 124, Issue 11, 2014, Pages 2513-2517

  Dall'Angelo, Anna ^a   Mandrini, Silvia ^a   Sala, Vittorio ^a   Pavese, Chiara ^a   Carlisi, Ettore ^c   Comelli, Mario ^b   Toffola, Elena D ^a,c  

^a Physical Medicine and Rehabilitation   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Botox ; Facial palsy; onabotulinumtoxinA; platysma; synkinesis

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL EVALUATION; EVALUATION STUDY; FACIAL EXPRESSION; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE ASSESSMENT; PLATYSMA MUSCLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SUNNYBROOK FACIAL GRADING SYSTEM; SYNKINESIS; VOLUNTARY MOVEMENT; COHORT ANALYSIS; COMPLICATION; CONVALESCENCE; DRUG EFFECTS; ESTHETICS; FACE MUSCLE; FACIAL PARALYSIS; INNERVATION; ITALY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PATIENT SATISFACTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS, TYPE A; COHORT STUDIES; ESTHETICS; FACIAL EXPRESSION; FACIAL MUSCLES; FACIAL PARALYSIS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; ITALY; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SYNKINESIS; TREATMENT OUTCOME;

EID: 84922277154     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24732     Document Type: Article

References (31)

1. Terzis JK, Karypidis D,. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg 2012; 129: 925e-939e.
2. Dalla Toffola E, Tinelli C, Lozza A, et al., Choosing the best rehabilitation treatment for Bell's palsy. Eur J Phys Rehabil Med 2012; 48: 635-642.
3. Gilden DH,. Clinical practice. Bell's Palsy. N Engl J Med 2004; 351: 1323-1331.
4. Choi D, Raisman G,. After facial nerve damage, regenerating axons become aberrant throughout the length of the nerve and not only at the site of the lesion: an experimental study. Br J Neurosurg 2004; 18: 45-48.
5. Sadjadpour K,. Postfacial palsy phenomena: faulty nerve regeneration or ephaptic transmission? Brain Res 1975; 95: 403-406.
6. Crumley RL,. Mechanisms of synkinesis. Laryngoscope 1979; 89: 1847-1854.
7. Moran CJ, Neely JG,. Patterns of facial nerve synkinesis. Laryngoscope 1996; 106: 1491-1496.
8. Husseman J, Mehta RP,. Management of synkinesis. Facial Plast Surg 2008; 24: 242-249.
9. Beurskens CH, Oosterhof J, Nijhuis-van der Sanden MW,. Frequency and location of synkinesis in patients with peripheral facial nerve paresis. Otol Neurotol 2010; 31: 671-675.
10. Bajaj-Luthra A, VanSwearingen J, Thornton RH, Johnson PC,. Quantitation of patterns of facial movement in patients with ocular to oral synkinesis. Plast Reconstr Surg 1998; 101: 1473-1480.
11. Vanswearingen J,. Facial rehabilitation: a neuromuscular reeducation, patient-centered approach. Facial Plast Surg 2008; 24: 250-259.
12. Laskawi R, Rohrbach S, Rodel R,. Surgical and nonsurgical treatment options in patients with movement disorders of the platysma. J Oral Maxillofac Surg 2002; 60: 157-162.
13. Henstrom DK, Malo JS, Cheney ML, Hadlock TA,. Platysmectomy: an effective intervention for facial synkinesis and hypertonicity. Arch Facial Plast Surg 2011; 13: 239-243.
14. Lindsay RW, Robinson M, Hadlock TA,. Comprehensive facial rehabilitation improves function in people with facial paralysis: a 5-year experience at the Massachusetts Eye and Ear Infirmary. Phys Ther 2010; 90: 391-397.
15. Dalla Toffola E, Furini F, Redaelli C, Prestifilippo E, Bejor M,. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010; 32: 1414-1418.
16. Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA,. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 2012; 122: 266-270.
17. Laskawi R, Damenz W, Roggenkamper P, Baetz A,. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol 1994: S195-S199.
18. Laskawi R,. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med 2008; 4: 5.
19. Chee GH, Nedzelski JM,. Facial nerve grading systems. Facial Plast Surg 2000; 16: 315-324.
20. Mehta RP, Hadlock TA,. Botulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg 2008; 10: 84-87.
21. Mehta RP, WernickRobinson M, Hadlock TA,. Validation of the Sinkinesis Assessment Questionnaire. Laryngoscope 2007; 117: 923-924.
22. Boahene K, Byrne P, Schaitkin BM,. Facial reanimation: discussion and debate. Facial Plast Surg Clin North Am 2012; 20: 383-402.
23. Kane MA,. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg 1999; 103: 656-663; discussion 664-665.
24. Becker-Wegerich PM, Rauch L, Ruzicka T,. Botulinum toxin a: successful decollete rejuvenation. Dermatol Surg 2002; 28: 168-171.
25. Matarasso A, Matarasso SL, Brandt FS, Bellman B,. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999; 103: 645-652; discussion 653-655.
26. Brandt FS, Bellman B,. Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 1998; 24: 1232-1234.
27. Levy PM,. The 'Nefertiti lift': a new technique for specific re-contouring of the jawline. J Cosmet Laser Ther 2007; 9: 249-252.
28. Carruthers J, Carruthers A,. Botulinum toxin A in the mid and lower face and neck. Dermatol Clin 2004; 22: 151-158.
29. Pavese C, Tinelli C, Furini F, et al., Validation of the Italian version of the Sunnybrook Facial Grading System. Neurol Sci 2013; 34: 457-463.
30. Ross BG, Fradet G, Nedzelski JM,. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996; 114: 380-386.
31. Kahn JB, Gliklich RE, Boyev KP, Stewart MG, Metson RB, McKenna MJ,. Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope 2001; 111: 387-398.